OTCMKTS:TEAR - TearLab Stock Price, News, Headlines & Rumors Sign in or create an account to add this stock to your watchlist. Get Started $0.1690 -0.02 (-10.58 %) (As of 08/16/2018 02:20 PM ET)Previous Close$0.1870Today's Range$0.1410 - $0.2052-Week Range$0.1211 - $2.20Volume33,449 shsAverage Volume48,658 shsMarket Capitalization$1.61 millionP/E Ratio-0.06Dividend YieldN/ABeta1.7 Company ProfileAnalyst RatingsChartEarnings HistoryFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, a single-use microfluidic microchip; TearLab pen, a hand-held device that interfaces with the TearLab disposable; and TearLab reader, a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corporation was founded in 1996 and is headquartered in San Diego, California. Receive TEAR News and Ratings via Email Sign-up to receive the latest news and ratings for TEAR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical SymbolOTCMKTS:TEAR CUSIPN/A Webwww.tearlab.com Phone858-455-6006 Debt Debt-to-Equity Ratio-1.33 Current Ratio1.52 Quick Ratio1.29 Price-To-Earnings Trailing P/E Ratio-0.06 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$27.12 million Price / Sales0.07 Cash FlowN/A Price / CashN/A Book Value($2.32) per share Price / Book-0.07 Profitability EPS (Most Recent Fiscal Year)($2.70) Net Income$-16,100,000.00 Net Margins-35.53% Return on EquityN/A Return on Assets-59.51% Miscellaneous Employees42 Outstanding Shares10,800,000Market Cap$1.61 million TearLab (OTCMKTS:TEAR) Frequently Asked Questions What is TearLab's stock symbol? TearLab trades on the OTCMKTS under the ticker symbol "TEAR." When did TearLab's stock split? How did TearLab's stock split work? TearLab's stock reverse split before market open on Friday, February 24th 2017. The 1-10 reverse split was announced on Friday, February 24th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 23rd 2017. An investor that had 100 shares of TearLab stock prior to the reverse split would have 10 shares after the split. How were TearLab's earnings last quarter? TearLab Corp (OTCMKTS:TEAR) issued its quarterly earnings results on Thursday, August, 9th. The medical research company reported ($0.06) earnings per share (EPS) for the quarter. The medical research company earned $6.41 million during the quarter. View TearLab's Earnings History. When is TearLab's next earnings date? TearLab is scheduled to release their next quarterly earnings announcement on Monday, November, 12th 2018. View Earnings Estimates for TearLab. What price target have analysts set for TEAR? 0 brokerages have issued 12-month target prices for TearLab's stock. Their forecasts range from $10,000,000.00 to $0.00. On average, they anticipate TearLab's share price to reach $0.00 in the next twelve months. This suggests that the stock has a possible downside of 100.0%. View Analyst Price Targets for TearLab. What is the consensus analysts' recommendation for TearLab? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TearLab in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." View Analyst Ratings for TearLab. Who are some of TearLab's key competitors? Some companies that are related to TearLab include Atossa Genetics (ATOS), Encision, Inc. Common Stock (ECIA), Calmare Therapeutics (CTTC), Invivo Therapeutics (NVIV), Delcath Systems (DCTHD), Cytori Therapeutics (CYTX), Amedica (AMDA), Delcath Systems (DCTH), AdvanSource Biomaterials Corpration Common Stock (ASNB), OxySure Therapeutics (OXYS), Quantrx Biomedical (QTXB), Scivanta Medical (SCVM), Lombard Medical (EVARF), Revolutions Medical (RMCP) and Oncologix Tech, Inc. Common Stock (OCLG). Who are TearLab's key executives? TearLab's management team includes the folowing people: Mr. Elias Vamvakas, Exec. Chairman & Sec. (Age 59)Mr. Joseph S. Jensen, CEO & Director (Age 46)Mr. Michael Marquez, Chief Financial Officer (Age 36)Dr. Benjamin Sullivan Ph.D., Chief Scientific Officer (Age 42)Mr. Sam Fakhoury, VP of Quality, Compliance & Supply Chain Has TearLab been receiving favorable news coverage? Headlines about TEAR stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group ranks the sentiment of news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. TearLab earned a daily sentiment score of 0.00 on Accern's scale. They also gave media headlines about the medical research company an impact score of 47.13 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. View Recent Headlines for TearLab. How do I buy shares of TearLab? Shares of TEAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is TearLab's stock price today? One share of TEAR stock can currently be purchased for approximately $0.1690. How big of a company is TearLab? TearLab has a market capitalization of $1.61 million and generates $27.12 million in revenue each year. The medical research company earns $-16,100,000.00 in net income (profit) each year or ($2.70) on an earnings per share basis. TearLab employs 42 workers across the globe. How can I contact TearLab? TearLab's mailing address is 9980 Huennekens Street Suite 100, San Diego CA, 92121. The medical research company can be reached via phone at 858-455-6006 or via email at [email protected] MarketBeat Community Rating for TearLab (OTCMKTS TEAR)Community Ranking: 3.2 out of 5 ( )Outperform Votes: 282 (Vote Outperform)Underperform Votes: 162 (Vote Underperform)Total Votes: 444MarketBeat's community ratings are surveys of what our community members think about TearLab and other stocks. Vote "Outperform" if you believe TEAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TEAR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 8/16/2018 by MarketBeat.com StaffFeatured Article: What is a closed-end mutual fund (CEF)?